$3.99
-0.03-0.75%
At close: Feb 13, 4:00 PM EST
$4.03
0.041.00%
After Hours: Feb 13, 7:07 AM EST
Comments
Loading...
ADC Therapeutics SA Earnings Estimates
ADCTNYSE
ADC Therapeutics Earnings Estimates, EPS & Revenue | NYSE:ADCT
ADC Therapeutics (ADCT) is scheduled to report Q4 earnings on March 26, 2026. Analysts estimate EPS of $-0.29 and quarterly revenue of $20.60M.
In the most recent quarter (Q3), ADC Therapeutics reported EPS of $-0.19, beating estimates of $-0.38 by 0.50%. Revenue came in at $16.43M, missing the estimate of $16.52M by 0.01%.
ADC Therapeutics has beaten EPS estimates in 7 consecutive quarters.
Over the last 4 quarters, ADC Therapeutics has averaged an EPS surprise of 0.38% and a revenue surprise of 0.11%.
Earnings Date
Mar 26
EPS Estimate
$-0.290
Quarterly Revenue Estimate
$20.60M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$75.21M
ADC Therapeutics Earnings History
Analyze the earnings history of ADC Therapeutics using advanced sorting and filters.
ADC Therapeutics (ADCT) Earnings Per Share
The chart below shows ADC Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $-0.19 | $-0.38 | 50.0 % |
| Q2 | 2025-08-12 | $-0.25 | $-0.36 | 30.6 % |
| Q1 | 2025-05-14 | $-0.22 | $-0.38 | 42.1 % |
| Q4 | 2025-03-27 | $-0.25 | $-0.35 | 28.6 % |
ADC Therapeutics (ADCT) Revenue
The chart below shows ADC Therapeutics's reported revenue compared to analyst estimates over recent quarters.
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $16.43M | $16.52M | -0.54 % |
| Q2 | 2025-08-12 | $18.84M | $18.21M | 3.46 % |
| Q1 | 2025-05-14 | $23.03M | $18.15M | 26.9 % |
| Q4 | 2025-03-27 | $16.91M | $19.67M | -14.0 % |
FAQ
When is ADC Therapeutics (NYSE:ADCT) reporting earnings?
ADC Therapeutics (ADCT) is scheduled to report earnings on May 13, 2026. The last reported earnings were for reported on November 10, 2025 for Q3.
What were the latest earnings per share (EPS) for ADC Therapeutics (NYSE:ADCT)?
The Actual EPS was $-0.19, which beat the estimate of $-0.38.
What were ADC Therapeutics’s (NYSE:ADCT) revenues?
The Actual Revenue was $16.43M, which missed the estimate of $16.52M.
